SETHURAMAN NATARAJAN (Chief Scientific Officer) received a stock award from ENTRADA THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/3/2026ACC: 0001873394-26-000001
Officer· Chief Scientific Officer
Since Oct 2021
+127.53K
Net shares
Net buyer
$134.5K
Total sold
0
Open market trades
0B · 0S
4
Total transactions
139K acquired · 11.47K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+55.80K
Price / share
—
Trade value
—
% of position
28.2%
3/1/2026
197.90K→253.70K
Common Stock
Direct
Shares
−3.90K
Price / share
$11.66
Trade value
$45.44K
% of position
1.5%
3/2/2026
253.70K→249.80K
Common Stock
Direct
Shares
−7.58K
Price / share
$11.76
Trade value
$89.08K
% of position
3.0%
3/3/2026
249.80K→242.22K
Total
Net shares
+44.33K
Net value
-$134.52K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/1/2026 | A · Award | +55.80K | — | — | 28.2% | 197.90K | 253.70K |
| Common Stock Direct | 3/2/2026 | F · Tax Withholding | −3.90K | $11.66 | $45.44K | 1.5% | 253.70K | 249.80K |
| Common Stock Direct | 3/3/2026 | F · Tax Withholding | −7.58K | $11.76 | $89.08K | 3.0% | 249.80K | 242.22K |
| Total | +44.33K | -$134.52K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
83.20K shares
Shares
+83.20K
Strike price
11.93
Held after
83.20K
Exercisable
—
3/1/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock83.20K shares | 3/1/2026 | A · Award | +83.20K | 11.93 | — | 83.20K |